XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Deficit Statement - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning (in shares) at Dec. 31, 2019     36,298          
Balance at beginning at Dec. 31, 2019 $ 104,151   $ 4 $ 535,954   $ 145 $ (431,952)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity component of convertible notes, net 58,543     58,543        
Warrants issued for common stock 737     737        
Common stock issued for stock options and restricted stock units (in shares)     948          
Common stock issued for stock options and restricted stock units 6,969     6,969        
Common stock issued for employee stock purchase plan (in shares)     50          
Common stock issued for employee stock purchase plan 1,122     1,122        
Exercise of common stock warrants, net (in shares)     407          
Tax withholdings related to net share settlements of restricted stock units (2,006)     (2,006)        
Stock-based compensation 4,303     4,303        
Net loss (38,624)           (38,624)  
Other comprehensive loss (61)         (61)    
Balance at end (in shares) at Mar. 31, 2020     37,703          
Balance at end at Mar. 31, 2020 135,134   $ 4 605,622   84 (470,576)  
Balance at beginning (in shares) at Dec. 31, 2019     36,298          
Balance at beginning at Dec. 31, 2019 104,151   $ 4 535,954   145 (431,952)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (65,757)              
Balance at end (in shares) at Jun. 30, 2020     37,937          
Balance at end at Jun. 30, 2020 114,688   $ 4 611,955   438 (497,709)  
Balance at beginning (in shares) at Mar. 31, 2020     37,703          
Balance at beginning at Mar. 31, 2020 135,134   $ 4 605,622   84 (470,576)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued for stock options and restricted stock units (in shares)     234          
Common stock issued for stock options and restricted stock units 2,673     2,673        
Stock-based compensation 3,660     3,660        
Net loss (27,133)           (27,133)  
Other comprehensive loss 354         354    
Balance at end (in shares) at Jun. 30, 2020     37,937          
Balance at end at Jun. 30, 2020 114,688   $ 4 611,955   438 (497,709)  
Balance at beginning (in shares) at Dec. 31, 2020     44,441          
Balance at beginning at Dec. 31, 2020 306,948 $ (51,012) $ 4 848,891 $ (58,543) 83 (542,030) $ 7,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued for stock options and restricted stock units (in shares)     726          
Common stock issued for stock options and restricted stock units 2,250   $ 1 2,249        
Common stock issued for employee stock purchase plan (in shares)     38          
Common stock issued for employee stock purchase plan 1,192     1,192        
Tax withholdings related to net share settlements of restricted stock units (2,585)     (2,585)        
Stock-based compensation 7,385     7,385        
Net loss (27,712)           (27,712)  
Other comprehensive loss (74)         (74)    
Balance at end (in shares) at Mar. 31, 2021     45,205          
Balance at end at Mar. 31, 2021 236,392   $ 5 798,589   9 (562,211)  
Balance at beginning (in shares) at Dec. 31, 2020     44,441          
Balance at beginning at Dec. 31, 2020 306,948 $ (51,012) $ 4 848,891 $ (58,543) 83 (542,030) $ 7,531
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (54,732)              
Balance at end (in shares) at Jun. 30, 2021     45,502          
Balance at end at Jun. 30, 2021 219,727   $ 5 809,015   (62) (589,231)  
Balance at beginning (in shares) at Mar. 31, 2021     45,205          
Balance at beginning at Mar. 31, 2021 236,392   $ 5 798,589   9 (562,211)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued for stock options and restricted stock units (in shares)     297          
Common stock issued for stock options and restricted stock units 2,255     2,255        
Stock-based compensation 8,171     8,171        
Net loss (27,020)           (27,020)  
Other comprehensive loss (71)         (71)    
Balance at end (in shares) at Jun. 30, 2021     45,502          
Balance at end at Jun. 30, 2021 $ 219,727   $ 5 $ 809,015   $ (62) $ (589,231)